healthNewsغير مصنف

Actelion receives Canada approval for Uptravi

ZURICH (Reuters) – Actelion Ltd , Europe’s biggest biotech firm, said on Tuesday that Health Canada had granted a notice of compliance for Uptravi, a new pulmonary arterial hypertension medicine.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى